GASTER control®

Modulating satiety perception through non-invasive biomechanical innovation

A CE-marked medical device applying controlled external abdominal compression to support appetite regulation within structured care pathways.

For healthcare professionals Explore the technology
CE-marked medical device
Prescription only
Patent pending
The concept

A mechanical approach to appetite regulation

GASTER control® applies controlled extra-parietal compression to the epigastric region, targeting the mechanical component of satiety. No pharmacological action, no internal device, no surgery — a purely external, adjustable, and reversible approach designed for daily use.

"Does not create satiety, but modulates the conditions in which it is perceived."
Adjustable
User-controlled compression adapted to individual morphology and tolerance
Non-invasive
Fully external, no contact with internal structures, no pharmacological mechanism
Meal-integrated
Designed for use before, during, and after meals in real-life conditions
Clinical positioning

A complementary tool within structured care pathways

GASTER control® is designed for integration alongside nutritional guidance, behavioral support, and pharmacological or surgical strategies — not as a standalone treatment.

Bariatric pathway

Pre-operative support and post-operative management of weight regain within surgical care trajectories.

GLP-1 transition

Support during dose reduction, treatment discontinuation, or as a non-pharmacological relay.

First-line option

Selected patients (BMI 27–30) not eligible for GLP-1 therapies, or seeking a non-invasive approach.

Full clinical information for prescribers
Exploratory data — n=11, 8 weeks

Early behavioral observations

91%
spontaneous portion reduction
81%
earlier satiety perception
3–6%
weight reduction
0
serious adverse events
Exploratory feasibility observation. These findings are hypothesis-generating and do not constitute proof of clinical efficacy. A multicentric observational registry is underway.
Scientific development

A structured clinical pathway

GASTER control® is currently undergoing multicentric observational evaluation (GC-REG-01) to document usage, tolerance, and behavioral outcomes in routine clinical practice.

~50 participants, BMI 25–40, 8-week follow-up with structured dietitian support. Data centralized on an HDS-certified platform (Obeli), with full GDPR compliance.

Multicentric registry currently enrolling
Scientific committee
MN
Dr Marius Nedelcu
Coordinating investigator — Bariatric surgeon
LM
Dr Ludivine Muzard
Nutritionist
AS
Dr Antoine Sina
Bariatric surgeon
AR
Dr Anthony Rouers
Bariatric surgeon
GC
Dr Gianfranco Calandra
Bariatric surgeon
CG
Dr Ciryl Gauthier
Investigating physician

How can we work together?

GASTER control® is open to collaboration across clinical, commercial, and industrial environments.

Healthcare professional

Clinical documentation, prescribing information, patient selection guidance, and training materials.

Access clinical resources
Distribution partner

Exclusive distribution, licensing agreements, and market-specific regulatory adaptation.

Explore partnership models
OEM integration

Integrate the BEP™ technology into your own wearable devices, medical textiles, or health platforms.

Discuss integration

A non-invasive biomechanical approach supporting the perception of satiety signals. Grounded in physiology, designed for clinical integration, and under continuous scientific evaluation.

Contact form